Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine

PharmacoEconomics
Gregory S Zaric

Abstract

Many interpretations of personalized medicine, also referred to as precision medicine, include discussions of companion diagnostic tests that allow drugs to be targeted to those individuals who are most likely to benefit or that allow treatment to be designed in a way such that individuals who are unlikely to benefit do not receive treatment. Many authors have commented on the clinical and competitive implications of companion diagnostics, but there has been relatively little formal analysis of the cost implications of companion diagnostics, although cost reduction is often cited as a significant benefit of precision medicine. We investigate the potential impact on costs of precision medicine implemented through the use of companion diagnostics. We develop a framework in which the costs of companion diagnostic tests are determined by considerations of profit maximization and cost effectiveness. We analyze four scenarios that are defined by the incremental cost-effectiveness ratio of the new drug in the absence of a companion diagnostic test. We find that, in most scenarios, precision medicine strategies based on companion diagnostics should be expected to lead to increases in costs in the short term and that costs would fall on...Continue Reading

References

Jul 1, 1994·Medical Decision Making : an International Journal of the Society for Medical Decision Making·S B Cantor
Mar 5, 2002·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Patricia Danzon, Adrian Towse
Dec 9, 2004·Pharmacogenomics·Kathryn A Phillips, Stephanie L Van Bebber
Sep 13, 2006·Health Affairs·Louis P Garrison, M J Finley Austin
Oct 24, 2008·The New England Journal of Medicine·Christos S KarapetisJohn R Zalcberg
Oct 25, 2011·Health Economics·Alan J GirlingTerry P Young
Mar 21, 2012·Molecular Oncology·Rahber TharianiScott Ramsey
May 12, 2012·New Biotechnology·Amit Agarwal
Nov 30, 2012·Clinical Chemistry·J Carl BarrettVijay Modur
Dec 19, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Eric FaulknerUNKNOWN Personalized Medicine Development and Reimbursement Working Group
Apr 12, 2013·Genetic Testing and Molecular Biomarkers·Yao-Shan Fan
Jun 15, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kenneth OffitRebecca Spence
Sep 27, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Adrian Towse, Louis P Garrison
Dec 12, 2013·Health Economics·Patricia DanzonJorge Mestre-Ferrandiz
Jan 22, 2014·The Cancer Journal·Roger D Klein
Nov 2, 2014·Nature Reviews. Drug Discovery·Charlotte Harrison
Jan 1, 2012·Journal of Personalized Medicine·Edward D BlairMartina Kaufmann
Jan 1, 2012·Journal of Personalized Medicine·Bradford R Hirsch, Amy P Abernethy
May 28, 2015·The New England Journal of Medicine·J Larry Jameson, Dan L Longo
Mar 1, 2013·Personalized Medicine·Robert D LieberthalNeil I Goldfarb
Jan 1, 2013·Personalized Medicine·Martina GarauDiego Ossa

❮ Previous
Next ❯

Citations

Jul 20, 2016·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·Joseph D Khoury
Aug 18, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Vladica M VeličkovićUwe Siebert
Apr 25, 2019·Expert Review of Molecular Diagnostics·Paul Hofman, Fabrice Barlesi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.